We are live on
!
Find out more
BCM
Blume Capital Management Portfolio holdings
AUM
$684M
1-Year Est. Return
41.68%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$191M
AUM Growth
+$8.08M
(+4.4%)
Cap. Flow
-$2.26M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
44.61%
Holding
206
New
11
Increased
19
Reduced
32
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$2.17M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$1.41M |
| 3 |
Goldman Sachs
GS
|
+$679K |
| 4 |
VanEck Oil Services ETF
OIH
|
+$498K |
| 5 |
CVS Health
CVS
|
+$331K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$1.95M |
| 2 |
Qualcomm
QCOM
|
+$1.31M |
| 3 |
GE Aerospace
GE
|
+$922K |
| 4 |
SLB Ltd
SLB
|
+$795K |
| 5 |
Apple
AAPL
|
+$566K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Financials | 14.93% |
| 3 | Energy | 13.11% |
| 4 | Healthcare | 11.29% |
| 5 | Communication Services | 11.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.54T
| $16.2M | 8.49% |
287,820
-10,860
| -4% | -$566K |
|
2
Johnson & Johnson
JNJ
$618B
| $8.43M | 4.4% |
60,985
+512
| +0.8% | +$68K |
|
3
Oracle
ORCL
$374B
| $8.33M | 4.35% |
161,500
-2,800
| -2% | -$136K |
|
4
iShares Biotechnology ETF
IBB
$9.34B
| $8.17M | 4.27% |
66,988
-988
| -1% | -$116K |
|
5
Microsoft
MSFT
$3.45T
| $8.06M | 4.21% |
70,471
-5,167
| -7% | -$560K |
|
6
Comcast
CMCSA
$85B
| $7.76M | 4.05% |
219,028
-1,700
| -0.8% | -$60.2K |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $7.6M | 3.97% |
39,911
-750
| -2% | -$138K |
|
8
Alphabet (Google) Class C
GOOG
$4.36T
| $7.15M | 3.74% |
119,820
-3,140
| -3% | -$188K |
|
9
Devon Energy
DVN
$52.1B
| $6.93M | 3.62% |
173,537
+100
| +0.1% | +$4.25K |
|
|
10
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $6.73M | 3.51% |
271,360
+87,290
| +47% | +$2.17M |
|
11
Wells Fargo
WFC
$261B
| $6.35M | 3.32% |
120,855
-2,380
| -2% | -$136K |
|
|
12
SLB Ltd
SLB
$73.6B
| $6.01M | 3.14% |
98,608
-12,350
| -11% | -$795K |
|
13
MetLife
MET
$61.9B
| $5.88M | 3.07% |
125,850
-2,726
| -2% | -$125K |
|
14
Capital One
COF
$128B
| $5.39M | 2.82% |
56,825
-725
| -1% | -$70.5K |
|
|
OAK
15
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $5.22M | 2.73% |
126,100
-3,850
| -3% | -$158K |
|
16
Walt Disney
DIS
$167B
| $4.64M | 2.42% |
39,649
-615
| -2% | -$68.5K |
|
|
17
CVS Health
CVS
$133B
| $3.99M | 2.08% |
50,670
+4,625
| +10% | +$331K |
|
18
Weyerhaeuser
WY
$18B
| $3.92M | 2.05% |
121,350
-200
| -0.2% | -$6.94K |
|
19
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $3.84M | 2.01% |
25,647
| – | – |
|
20
General Motors
GM
$80.4B
| $3.75M | 1.96% |
111,476
-1,400
| -1% | -$51.6K |
|
|
21
Qualcomm
QCOM
$155B
| $3.73M | 1.95% |
51,735
-19,905
| -28% | -$1.31M |
|
22
Intel
INTC
$455B
| $3.71M | 1.94% |
78,365
-4,050
| -5% | -$197K |
|
23
Kinder Morgan
KMI
$71.7B
| $3.45M | 1.8% |
194,655
-4,850
| -2% | -$86.7K |
|
|
24
Goldman Sachs
GS
$300B
| $3.33M | 1.74% |
14,840
+2,920
| +24% | +$679K |
|
25
JPMorgan Chase
JPM
$935B
| $3.32M | 1.74% |
29,461
-200
| -0.7% | -$22.7K |
|
Similar funds
HCP
TWM
HWM
ECM
DMC
NS
CIA
CCG
Blume Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Blume Capital Management held 206 positions worth $191M, up 4.4% from $183M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Blume Capital Management's Q3 2018 filing shows 11 new, 19 increased, 32 reduced and 5 closed positions. Its largest new stake was Micron Technology: 1,700 shares worth $77K. The largest sale was GSK, an estimated $1.95M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Energy.
- Blume Capital Management's largest Q3 2018 buy was Micron Technology: 1,700 shares worth $77K.
- Blume Capital Management added most to Schwab Short-Term US Treasury ETF in Q3 2018, an estimated $2.17M increase.
- Blume Capital Management's biggest Q3 2018 reduction was GSK, cutting an estimated $1.95M.
- Blume Capital Management fully exited Chubb in Q3 2018, selling an estimated $51K.
- Blume Capital Management's ten largest holdings make up 45% of its $191M portfolio in Q3 2018.
- Blume Capital Management opened 11 new positions and closed 5 in Q3 2018.
- Blume Capital Management's portfolio value rose 4.4% quarter-over-quarter to $191M.
Based on Blume Capital Management's 13F filing for Q3 2018, filed 2 Nov 2018.